Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
CANTON, Conn., April 25, 2012 /PRNewswire/ -- Kelyniam (Pinksheets: KLYG.PK), is pleased to announce first quarter 2012 revenues of $210,635, a four-fold increase from the fourth quarter of 2011. The increase in revenues was driven by surgeries at new hospitals and from surgeons who have converted to using the Kelyniam Custom Skull Implant made from PEEK material.
Renasant Corporation Announces 2012 First Quarter Earnings
TUPELO, Miss., April 24, 2012 /PRNewswire/ -- Renasant Corporation (NASDAQ: RNST) (the "Company") today announced its financial results for the first quarter of 2012. Net income for the first quarter of 2012 was $5,974,000, or basic and diluted earnings per share of $0.24, as compared to $5,790,000, or basic and diluted earnings per share of $0.23, for the fourth quarter of 2011. Net income for the first quarter of 2011 was $7,553,000, or basic and diluted earnings per share of $0.30, and included a pre-tax gain of $8,774,000 and pre-tax merger-related costs of $1,325,000 in connection with the American Trust FDIC-assisted acquisition.
"Our first quarter 2012 financial results reflect our continued focus in several key areas, specifica ...
Johnson & Johnson Reports 2012 First-Quarter Results:
NEW BRUNSWICK, N.J., April 17, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $16.1 billion for the first quarter of 2012, a decrease of 0.2% as compared to the first quarter of 2011. Operational results increased 1.0% and the negative impact of currency was 1.2%.
| Related News: |
